Zenas BioPharma Inc., a clinical-stage global biopharmaceutical company focused on therapies for autoimmune diseases, is set to present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 1:25 p.m. ET. A live webcast and archived replay of the presentation will be available on the company's website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zenas Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9459738-en) on May 29, 2025, and is solely responsible for the information contained therein.